Building for big pharma
2013
With acquisition the most likely exit for today's biotech investors, it pays to keep current with the tastes of pharmaceutical firms when launching a venture.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
2
References
8
Citations
NaN
KQI